Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General

FDA Says Case-by-case Release Of Some Abbott Amino Acid-Based & Metabolic Infant Formula Has Provided Products To 2,958 Infants & Individuals In Need; Says To Date, ~500K Containers Of Additional Product Remain Accessible To Those In Need

By Bill Haddad
July 1, 3:54 PM
-Reuters

ABT

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Interview
  • Long Ideas
  • Tech
  • Trading Ideas

‘How Do You Not Like Apple?’: How CNBC’s Todd Gordon Is Investing In A Volatile Market

By Wayne Duggan
July 1, 3:53 PM
Todd Gordon, CNBC contributor and founder of New Age Wealth Advisors, joined Benzinga's PreMarket Prep show on Friday morning. Gordon discussed the S&P 500 market weakness so far in 2022 and how he is positioning his clients' money heading into the second half of the year.

AAPL

Read More
1 minute read
  • General
  • Health Care

Traders Circulate NYT Article Titled ‘Will There Be Enough Monkeypox Vaccine?’

By Bill Haddad
July 1, 3:49 PM
https://www.nytimes.com/2022/07/01/health/monkeypox-vaccine-bavarian-nordic.html

AEMD

Read More
1 minute read
  • Cryptocurrency
  • Markets

Meta’s Cryptocurrency Wallet Novi Says Will No Longer Be Available Starting September 1, 2022 On WhatsApp

By Bill Haddad
July 1, 3:45 PM
-Reuters

META

Read More
1 minute read
  • General
  • Markets
  • Media
  • Trading Ideas

Hot Stocks: Tickers Moved By Traders on ‘Fast Money: Halftime Report’

By AJ Fabino
July 1, 3:44 PM
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

BMY

Read More
1 minute read
  • Cryptocurrency
  • General
  • M&A
  • Markets
  • Media
  • News

FTX Bails Out BlockFi, Has Option To Purchase For Up To $240 Million: What You Need To Know

By AJ Fabino
July 1, 3:41 PM
After numerous days of conflicting reports leaving BlockFi investors and crypto watchers on edge, company CEO Zac Prince took to Twitter on Friday to announce that FTX signed a deal to bail out the embattled crypto firm.

TWTR

Read More
1 minute read
  • M&A
  • News

Sensata Divests Qinex Business; Eyes Funding Electrification & Insights/IoT

By Akanksha Bakshi
July 1, 3:39 PM
Sensata Technologies Holding PLC (NYSE:ST) sold its Qinex semiconductor thermal test and control business to Boyd Corporation for $219 million, including…

ST

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Penny Stocks

HC Wainwright Finds ‘Synergies In Treatment’ For This Bipolar-Focused Stock

By Vandana Singh
July 1, 3:39 PM
HC Wainwright initiated coverage on NRx Pharmaceuticals Inc (NASDAQ:NRXP) with a Buying rating and a price target of $2. Earlier today, the FDA…

GILD

Read More
4 minute read
  • Earnings
  • News

Cinedigm Issue Corrected Q4 Earnings Report: EPS $(0.01), Up From $(0.05) YoY

By Bill Haddad
July 1, 3:38 PM
Consolidated Fourth Quarter Revenue of $16.9 Million Up 104% Over Prior Year Led by Record Streaming Revenue Consolidated Full Year Revenue of $56.1 Million Up 78% Over Prior Year Streaming Revenue Up 108% Over Prior

CIDM

Read More
2 minute read
  • Markets
  • Options

This Is What Whales Are Betting On Qualcomm

By Benzinga Insights
July 1, 3:34 PM
A whale with a lot of money to spend has taken a noticeably bearish stance on Qualcomm. Looking at options history for Qualcomm (NASDAQ:QCOM) we detected 89 strange trades.

QCOM

Posts pagination

Previous 1 … 19,038 19,039 19,040 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service